Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Scientific Industries, Inc. is a U.S.-based manufacturer and distributor of laboratory equipment and bioprocessing systems, serving the life sciences, clinical diagnostics, and industrial research markets. The company is best known for its laboratory mixing, stirring, and shaking devices, as well as its more recent expansion into single-use bioprocessing solutions. Its revenue is primarily driven by sales of proprietary laboratory instruments, consumables, and bioprocessing systems to research laboratories, biotechnology companies, pharmaceutical manufacturers, and academic institutions.
Founded in 1954, Scientific Industries initially built its reputation around the development of the Vortex® mixer, a widely adopted laboratory instrument that remains a core product line today. Over time, the company expanded its portfolio to include benchtop shakers, incubators, and magnetic stirrers, and later diversified into bioprocessing technologies through acquisitions and internal development. The company operates as a niche provider with long-standing brand recognition in laboratory equipment, positioning itself around durability, reliability, and installed-base replacement demand.
Business Operations
Scientific Industries operates primarily through two core business segments: Laboratory Equipment and Bioprocessing Systems. The Laboratory Equipment segment includes vortex mixers, shakers, incubators, and related accessories, which are sold directly and through distributors. This segment represents the company’s historical foundation and generates recurring revenue through replacement demand and accessory sales.
The Bioprocessing Systems segment focuses on single-use bioreactors and related systems designed for cell culture and biologics production. These products are targeted at biotechnology and pharmaceutical customers seeking flexible and scalable manufacturing solutions. Operations include domestic manufacturing and assembly in the United States, with international sales supported through third-party distributors. The company controls proprietary designs and manufacturing processes for its core products and maintains wholly owned operating subsidiaries to manage product lines.
Strategic Position & Investments
Scientific Industries’ strategic direction emphasizes leveraging its established laboratory equipment brand while expanding higher-growth opportunities in bioprocessing. Growth initiatives have centered on product development within single-use technologies and expanding the commercial reach of bioprocessing systems into biologics and advanced therapy manufacturing. The company has pursued selective acquisitions to accelerate this strategy, most notably the acquisition of Helix Biotech GmbH, which formed the foundation of its bioprocessing platform.
Investment priorities include research and development aimed at improving system scalability, automation compatibility, and regulatory alignment for biopharmaceutical production. Management has indicated a focus on disciplined capital allocation, balancing incremental innovation in legacy products with longer-term investment in emerging bioprocessing applications. While bioprocessing represents a smaller portion of revenue compared to laboratory equipment, it is positioned as a strategic growth driver.
Geographic Footprint
Scientific Industries is headquartered in New York, United States, and maintains primary operations and manufacturing within North America. The company sells products globally, with international revenue generated through distributors and partners across Europe, Asia, and other international markets. Its bioprocessing subsidiary operations in Germany provide a direct presence in the European biotechnology market.
The company’s geographic footprint reflects a hybrid model of centralized manufacturing and decentralized sales, allowing it to serve academic, industrial, and pharmaceutical customers across multiple continents. While the majority of revenue is derived from the United States, international markets represent an important component of long-term growth, particularly for bioprocessing systems.
Leadership & Governance
Scientific Industries is led by an executive team with experience in laboratory instrumentation, manufacturing, and life sciences commercialization. The company operates under a traditional public-company governance structure and is overseen by a board of directors responsible for strategic oversight and fiduciary governance.
Key executives include:
- John W. Moore – President and Chief Executive Officer
- Gary M. Nachman – Chief Financial Officer
- Jeffrey E. Johnson – Vice President of Operations
- Christian Wurm – Managing Director, Bioprocessing Operations
Leadership has articulated a strategic vision focused on operational discipline, measured expansion into bioprocessing technologies, and maximizing value from its established laboratory equipment franchise while pursuing sustainable long-term growth.